These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Time-limited phototherapy of term newborns in ABO hemolytic disease and hyperbilirubinaemia. Rosta J; Makoi Z; Békefi D; Várady J Perinat Med; 1975; 3(3):198-203. PubMed ID: 1240143 [TBL] [Abstract][Full Text] [Related]
69. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017. Flaherman VJ; Maisels MJ; Breastfeed Med; 2017 Jun; 12(5):250-257. PubMed ID: 29624434 [No Abstract] [Full Text] [Related]
70. [Importance of the determination of bilirubin not bound to albumin on a sephadex gel column in neonatal jaundice]. Rusu O; Popa M; Nanu R; Taulescu G Pediatria (Bucur); 1973; 22(1):75-82. PubMed ID: 4798769 [No Abstract] [Full Text] [Related]
71. [Importance of the determination of bilirubin not bound to albumin on a sephadex gel column in neonatal jaundice]. Rusu O; Popa M; Nanu R; Taulescu G Pediatria (Bucur); 1973; 22(1):75-82. PubMed ID: 4739035 [No Abstract] [Full Text] [Related]
72. [Closed system exchange transfusion of newborn infants (data from 1966 to 1970)]. Kora'nyi D; Pesthi E Pediatriia; 1972 Jun; 51(6):58-62. PubMed ID: 4626061 [No Abstract] [Full Text] [Related]
73. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program. Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540 [TBL] [Abstract][Full Text] [Related]
74. [Fototherapy of neonatal hyperbilirubinemia. Results of its clinical application (author's transl)]. Hohenauer L; Haschke F; Gerstl JW Klin Padiatr; 1976 Jul; 188(4):314-9. PubMed ID: 988423 [TBL] [Abstract][Full Text] [Related]
75. [Isoagglutinins of the ABO system in universal blood preparations (KU-ABO) used for exchange transfusions in hemolytic disease of the newborn]. Cwik J Pediatr Pol; 1985 Sep; 60(9):652-7. PubMed ID: 3831898 [No Abstract] [Full Text] [Related]
77. [Results of 2 prospective surveys on phototherapy of neonatal jaundice in 274 subjects. Study of the influence of light energy intensity and continuous or discontinuous mode of treatment]. Caldera R; Maigret P; Maynier M; Larbey P; Fermanian J; Dahan R Ann Pediatr (Paris); 1984 Apr; 31(4):297-301. PubMed ID: 6430204 [No Abstract] [Full Text] [Related]
78. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726 [TBL] [Abstract][Full Text] [Related]
79. [The place of determination of unbound bilirubin and serum albumin in the surveillance of jaundice in the premature infant]. Satge P; Colin J; Voyer M; Crumiere C; Charlas J Arch Fr Pediatr; 1974; 31(2):201-13. PubMed ID: 4859164 [No Abstract] [Full Text] [Related]
80. [Place of phototherapy in the treatment of jaundice in the newborn]. Farriaux JP; Wackenier JP; Blanckaert D; Hongre JF; Sauvage R Lille Med; 1973 Apr; 18(4):403-14. PubMed ID: 4795733 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]